Details of the Drug
- Generic Name:
- Drug Type:
- Selective T cell co-stimulation modulator
- How the Drug is Given:
Injection, for intravenous use; Injection, for subcutaneous use
Indications and Usage
Abatacept is a indicated for the prophylaxis (prevention) of acute graft versus host disease (aGVHD), in combination with a calcineurin inhibitor and methotrexate, in adults and pediatric patients 2 years of age and older undergoing hematopoietic stem cell transplantation (HSCT) from a matched or 1 allele-mismatched unrelated donor.
Side effects needing medical attention
Most common adverse events are anemia, hypertension, CMV reactivation/CMV infection, fever, pneumonia, nose bleeds, CD4 lymphocytes decreased, hypermagnesemia, and acute kidney injury.
For information on how to manage the costs of drug therapy, please see Financial Support, or to speak with an Information Specialist, call (800) 955-4572.